ArticleCancers2022

Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit.

Tomohisa Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.